These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 23987068)

  • 1. [Anticancer activity of oxovanadium compounds].
    Abakumova OIu; Podobed OV; Beliaeva NF; Tochilkin AI
    Biomed Khim; 2013; 59(3):305-20. PubMed ID: 23987068
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bis(4,7-dimethyl-1,10-phenanthroline) sulfatooxovanadium(IV) as a novel apoptosis-inducing anticancer agent.
    Narla RK; Dong Y; D'Cruz OJ; Navara C; Uckun FM
    Clin Cancer Res; 2000 Apr; 6(4):1546-56. PubMed ID: 10778988
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective hypoxia-cytotoxins based on vanadyl complexes with 3-aminoquinoxaline-2-carbonitrile-N1,N4-dioxide derivatives.
    Vieites M; Noblía P; Torre MH; Cerecetto H; Laura Lavaggi M; Costa-Filho AJ; Azqueta A; de Cerain AL; Monge A; Parajón-Costa B; González M; Gambino D
    J Inorg Biochem; 2006 Aug; 100(8):1358-67. PubMed ID: 16698084
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Synthesis and hypoglycemic activity of bis(L-malato)oxovanadium(IV)].
    Gorodetskiĭ VK; Tochilkin AI; Beliaeva NF; Kovel'man IR; Korovkin BF
    Biomed Khim; 2011; 57(1):133-7. PubMed ID: 21516785
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new halogenated antidiabetic vanadyl complex, bis(5-iodopicolinato)oxovanadium(IV): in vitro and in vivo insulinomimetic evaluations and metallokinetic analysis.
    Takino T; Yasui H; Yoshitake A; Hamajima Y; Matsushita R; Takada J; Sakurai H
    J Biol Inorg Chem; 2001 Feb; 6(2):133-42. PubMed ID: 11293406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of cellular uptake, cytotoxicity and cellular ultrastructural effects of heteroleptic oxidovanadium(IV) complexes of salicylaldimines and polypyridyl ligands.
    Scalese G; Correia I; Benítez J; Rostán S; Marques F; Mendes F; Matos AP; Costa Pessoa J; Gambino D
    J Inorg Biochem; 2017 Jan; 166():162-172. PubMed ID: 27865131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new insulin-mimetic vanadyl complex, (N-pyridylmethylaspartate)oxovanadium(IV) with VO(N2O2) coordination mode, and evaluation of its effect on uptake of D-glucose by Ehrlich ascites tumour cells.
    Tawa R; Uchida K; Taniyama J; Fujisawa Y; Fujimoto S; Nagaoka T; Kanamori K; Sakurai H
    J Pharm Pharmacol; 1999 Feb; 51(2):119-24. PubMed ID: 10217308
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis, X-ray structure, and anti-leukemic activity of oxovanadium(IV) complexes.
    Dong Y; Narla RK; Sudbeck E; Uckun FM
    J Inorg Biochem; 2000 Mar; 78(4):321-30. PubMed ID: 10857913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vanadyl complexes discriminate between neuroblastoma cells and primary neurons by inducing cell-specific apoptotic pathways.
    Zhang Y; Wang L; Zeng K; Wang K; Yang X
    J Inorg Biochem; 2018 Nov; 188():76-87. PubMed ID: 30121400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antioxidant, DNA cleavage, and cellular effects of silibinin and a new oxovanadium(IV)/silibinin complex.
    Naso LG; Ferrer EG; Butenko N; Cavaco I; Lezama L; Rojo T; Etcheverry SB; Williams PA
    J Biol Inorg Chem; 2011 Apr; 16(4):653-68. PubMed ID: 21399988
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An orally active antidiabetic vanadyl complex, bis(1-oxy-2-pyridinethiolato)oxovanadium(IV), with VO(S2O2) coordination mode; in vitro and in vivo evaluations in rats.
    Sakurai H; Sano H; Takino T; Yasui H
    J Inorg Biochem; 2000 May; 80(1-2):99-105. PubMed ID: 10885469
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bis(oxalato)dioxovanadate(V) and bis(oxalato)oxoperoxo-vanadate(V) complexes: spectroscopic characterization and biological activity.
    León IE; Etcheverry SB; Parajón-Costa BS; Baran EJ
    Biol Trace Elem Res; 2013 Nov; 155(2):295-300. PubMed ID: 24026441
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of nanofunctionalized oxovanadium(IV) complex and its anticancer, antidiabetic, DNA cleavage and cell imaging studies.
    Sunitha N; Isac Sobana Raj C; Sindhu Kumari B
    Int J Pharm; 2023 Sep; 644():123339. PubMed ID: 37611853
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the glucose-lowering properties of vanadyl sulfate and bis(maltolato)oxovanadium(IV) following acute and chronic administration.
    Yuen VG; Orvig C; McNeill JH
    Can J Physiol Pharmacol; 1995 Jan; 73(1):55-64. PubMed ID: 7600453
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytotoxic effect of xyloglucan and oxovanadium (IV/V) xyloglucan complex in HepG2 cells.
    Escaliante LADS; Busato B; Petkowicz CLO; Cadena SMSC; Noleto GR
    Int J Biol Macromol; 2021 Aug; 185():40-48. PubMed ID: 34144065
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure-dependent metallokinetics of antidiabetic vanadyl-picolinate complexes in rats: studies on solution structure, insulinomimetic activity, and metallokinetics.
    Yasui H; Tamura A; Takino T; Sakurai H
    J Inorg Biochem; 2002 Jul; 91(1):327-38. PubMed ID: 12121792
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apoptosis-inducing oxovanadium(IV) complexes of 1,10-phenanthroline against human ovarian cancer.
    D'Cruz OJ; Dong Y; Uckun FM
    Anticancer Drugs; 2000 Nov; 11(10):849-58. PubMed ID: 11142693
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vanadyl-biguanide complexes as potential synergistic insulin mimics.
    Woo LC; Yuen VG; Thompson KH; McNeill JH; Orvig C
    J Inorg Biochem; 1999 Sep; 76(3-4):251-7. PubMed ID: 10605840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spermicidal activity of oxovanadium(IV) complexes of 1, 10-phenanthroline, 2,2'-bipyridyl, 5'-bromo-2'-hydroxyacetophenone and derivatives in humans.
    D'Cruz OJ; Dong Y; Uckun FM
    Biol Reprod; 1999 Feb; 60(2):435-44. PubMed ID: 9916012
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis, immunomodulation and cytotoxic effects of vanadium (IV) complexes.
    Ashiq U; Jamal RA; Mesaik MA; Mahroof-Tahir M; Shahid S; Khan KM
    Med Chem; 2014 May; 10(3):287-99. PubMed ID: 23876231
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.